Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

about

Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas.Pathology-MRI Correlations in Diffuse Low-Grade Epilepsy Associated Tumors.Pediatric Glioma at the Optic Pathway and Thalamus.

P2860

Q38962187-6ECB92AF-7AA4-4B0F-9E4F-A186F83BCE7E Q48014811-1A6CABA1-43E2-4580-888B-14B7EEA9B783 Q55333228-569DEF5C-A03A-4935-8D30-E220B3094E84

P2860

Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

Item

http://www.wikidata.org/entity/Q38365733

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

@en

type

Item

label

Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

@en

prefLabel

Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

@en

P1476

Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

@en

P2093

Jason Wang

http://www.w3.org/2001/XMLSchema#string

Soumen Khatua

http://www.w3.org/2001/XMLSchema#string

Veena Rajaram

http://www.w3.org/2001/XMLSchema#string

P2860

Profiling critical cancer gene mutations in clinical tumor samples

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

The 2007 WHO classification of tumours of the central nervous system

Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway.

Determinants of BRAF mutations in primary melanomas

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

P2888

s00381-015-2653-2

P304

643-652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00381-015-2653-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272835052

http://www.w3.org/2001/XMLSchema#string

P6179

1027758785

http://www.w3.org/2001/XMLSchema#string

P698

25722047

http://www.w3.org/2001/XMLSchema#string

Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

about

P2860

P2860

Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698